Asherman Syndrome

Asherman's syndrome, also known as Asherman's symptom complex, is a rare condition that causes scarring or adhesions to form inside the uterus in women. This syndrome can lead to menstrual irregularities, infertility, abortion and other problems with the reproductive system.

The syndrome was named after Joseph Asherman, who first described this pathology in women in 1948. He suggested that this syndrome could result from trauma or infection of the uterus caused by abortion or childbirth. However, it later became known that the syndrome can also occur as a result of other factors, such as surgical interventions in the uterus, radical treatments for endometriosis, inflammatory processes and others.

The main symptom of Asherman's syndrome is menstrual irregularity. A woman may experience unusually short periods, irregular cycles, or no periods at all. However, in some women the syndrome may not show any symptoms.

To diagnose Asherman's syndrome, a number of tests may be required, such as ultrasound examination of the uterus, hysteroscopy and hysterosalpingography. Once diagnosed, treatment may include surgical interventions such as laparoscopy and hysteroscopy, as well as hormone therapy to restore reproductive function.

Overall, Asherman's syndrome is a rare disease that can lead to serious problems with the reproductive system in women. Understanding the causes and mechanisms of development of this syndrome can help in the development of more effective diagnostic and treatment methods. It is important to see a doctor if you suspect you have this disease to get timely help and prevent possible complications.



Asherman's syndrome (AS) is a rare acquired obstetric and gynecological complicated syndrome, manifested by sclerotic replacement of the decidual tissue of the uterus, endometrium, tubes and uterine angles. The basis of the disease is the adhesive process after operations, inflammatory diseases and early delivery. As a rule, mostly young women with two or more children suffer, but the incidence is no more than 2% of the total number of women who gave birth.